Abstract
Estrogenic and androgenic steroids synthesized in the brain may rapidly modulate synaptic plasticity interacting with specific membrane receptors. We explored by electrophysiological recordings in hippocampal slices of male rat the influence of 17β-estradiol (E2) and 5α-dihydrotestosterone (DHT) neo-synthesis on the synaptic changes induced in the CA1 region. Induction of long-term depression (LTD) and depotentiation (DP) by low frequency stimulation (LFS, 15 min-1 Hz) and of long-term potentiation (LTP) by high frequency stimulation (HFS, 1 s-100 Hz), medium (MFS, 1 s-50 Hz), or weak (WFS, 1 s-25 Hz) frequency stimulation was assayed under inhibitors of enzymes converting testosterone (T) into DHT (5α-reductase) and T into E2 (P450-aromatase). We found that LFS-LTD depends on DHT synthesis, since it was fully prevented under finasteride, an inhibitor of DHT synthesis, and rescued by exogenous DHT, while the E2 synthesis was not involved. Conversely, the full development of HFS-LTP requires the synthesis of E2, as demonstrated by the LTP reduction observed under letrozole, an inhibitor of E2 synthesis, and its full rescue by exogenous E2. For intermediate stimulation protocols DHT, but not E2 synthesis, was involved in the production of a small LTP induced by WFS, while the E2 synthesis was required for the MFS-dependent LTP. Under the combined block of DHT and E2 synthesis all stimulation frequencies induced partial LTP. Overall, these results indicate that DHT is required for converting the partial LTP into LTD whereas E2 is needed for the full expression of LTP, evidencing a key role of the neo-synthesis of sex neurosteroids in determining the direction of synaptic long-term effects.
Keywords: 17β-estradiol, 5α-dihydrotestosterone, P450-aromatase, 5α-reductase, hippocampus, long-term potentiation, long-term depression, depotentiation
Introduction
Synaptic long-term potentiation (LTP) and long-term depression (LTD) are usually induced in the hippocampus by high frequency stimulation (HFS) and low frequency stimulation (LFS), respectively, and are commonly regarded as the cellular substrate for learning and memory (Bliss and Lomo, 1973; Staubli and Lynch, 1990; Bliss and Collingridge, 1993; Dudek and Bear, 1993; Bear and Malenka, 1994; Staubli and Ji, 1996; Martin et al., 2000). LTP and LTD are considered models of bidirectionally-changeable plasticity that are generally dependent on NMDA receptor (NMDAR) activation followed by postsynaptic Ca2+ influx, able to trigger Ca2+-dependent signaling pathways in many brain regions such as the hippocampus, in particular at the level of the Schaffer collateral-CA1 synapse (Bliss and Collingridge, 1993; Malenka and Nicoll, 1999; Malenka and Bear, 2004). Therefore, the direction of the change of synaptic strength depends on afferent stimulation causing different activation of NMDAR-dependent Ca2+ signaling (Dudek and Bear, 1992, 1993; Mulkey and Malenka, 1992; Bear and Malenka, 1994; Cummings et al., 1996). Thus, a larger HFS-dependent Ca2+ entry leads to LTP (Bliss and Collingridge, 1993; Bear and Malenka, 1994), while moderate Ca2+ influx caused by LFS induces LTD in naïve synapses or de-potentiation (DP) in potentiated synapses (Staubli and Lynch, 1990; Dudek and Bear, 1992, 1993; Bear and Malenka, 1994; Staubli and Ji, 1996).
Growing evidence suggest that the sex steroids 17β-estradiol (E2), testosterone (T) and 5α-dihydrotestosterone (DHT) may participate in rapidly modulating the long-term synaptic effects in different areas of the brain (McEwen, 2002; Isgor and Sengelaub, 2003; MacLusky et al., 2006; Hajszan et al., 2008) interacting with membrane receptors for E2 (ERs) and androgens (ARs; Kerr et al., 1995; Milner et al., 2001, 2005; Kalita et al., 2005; Tabori et al., 2005; Pedram et al., 2006; Foradori et al., 2008; Morissette et al., 2008; Raz et al., 2008; Levin, 2009). In particular, it has been shown that E2 can increase the NMDAR-mediated glutamatergic transmission, decrease the GABAergic one and enhance the magnitude of LTP at hippocampal CA3-CA1 glutamatergic synapses (Wong and Moss, 1992; Woolley et al., 1997; Murphy et al., 1998; Foy et al., 1999; Foy, 2001; Rudick and Wooley, 2001; Smith and McMahon, 2005, 2006; Smith et al., 2009; Hasegawa et al., 2015), while T and DHT show an opposite effect (Harley et al., 2000; Hebbard et al., 2003; Skucas et al., 2013; Hasegawa et al., 2015).
We recently reported that in hippocampal slices of male rats, estrogenic and androgenic signals are selectively involved in the induction of LTP or LTD/DP in response to specific synaptic activation (Pettorossi et al., 2013). Moreover, it has been found, by blocking ERs and ARs that E2 is implied in the LTP induced by HFS, while androgens in LTD/DP induced by LFS. This opposite influence of sex steroids on synaptic plasticity could be exerted by either the circulating steroids of gonadal origin or steroids synthesized in the nervous system from cholesterol (Baulieu, 1997; Compagnone and Mellon, 2000) and the subsequent conversion of T into E2 and DHT by P450-aromatase and 5α-reductase enzymes, respectively (Selmanoff et al., 1977; Kimoto et al., 2001; Hojo et al., 2004, 2008, 2009; Mukai et al., 2006). It is important to distinguish the specific influence of neurosteroids synthetized de-novo within the central nervous system (CNS) from that of circulating steroids since the neo-synthesis may directly reflect the functional conditions of CNS and may vary depending on the neuronal activity per se (Kimoto et al., 2001; Hojo et al., 2004, 2008, 2009; Balthazart and Ball, 2006; Balthazart et al., 2006; Mukai et al., 2006; Ooishi et al., 2012). The relevance of the sex neurosteroid synthesis is evidenced by their concentration in the nervous system that is significantly higher than that in the circulatory system (Selmanoff et al., 1977; Kimoto et al., 2001; Hojo et al., 2004, 2008, 2009; Mukai et al., 2006).
We previously reported that HFS-LTP is markedly reduced by the blocking agent for the P450-aromatase activity, letrozole (Grassi et al., 2009, 2011; Tanaka and Sokabe, 2012; Vierk et al., 2012, 2014), supporting the involvement of the E2 neo-synthesized within the CNS in the induction of LTP. However, the possible contribution of neo-synthesis of E2 in LTP and LTD induced by different stimulation patterns, or the role of the neo-synthesis of androgens in LTP and LTD has not been addressed.
Therefore, in the present study we directly assessed, in the hippocampal slices of male rat, the role of E2 and DHT neo-syntheses and their possible interaction in the induction of LTD/DP and LTP focusing on the Schaffer collateral-CA1 synaptic region where the LTP is known to be NMDAR dependent. For this purpose, we analyzed the effect of different stimulation patterns in the presence of inhibitors of the P450-aromatase and/or the 5α-reductase enzymes.
Material and Methods
Ethic Statement on Animal Use
All procedures on animals were conducted in conformity with the guidelines of the Italian Ministry of Health, national laws on animal research (Legislative Decree 26/2014) and European Communities Council Directive (86/609/ECC), in accordance with protocols approved by the Animal Care and Use Committee at the University of Perugia (Italy). Wistar rats (Harlan, Italy) (2 per cage) were kept under regular lighting conditions (12 h light/dark cycle) and given food and water ad libitum. All efforts were made to minimize the number of animals used and their suffering.
Electrophysiology
The study was conducted in 281 hippocampal slices prepared from 112 male Wistar rats at P50–60. We used male rats to avoid any possible influence of cyclic, systemic estrogenic fluctuation on the induction of synaptic plasticity (Warren et al., 1995; Good et al., 1999). Animals were sacrificed under deep halothane anesthesia, by cervical dislocation. The brain was rapidly removed and immersed for 2–3 min in ice-cold ACSF containing (in mM): 126 NaCl, 2.5 KCl, 1.2 MgCl2, 1.2 NaH2PO4, 2.4 CaCl2, 10 glucose, and 25 NaHCO3, continuously bubbled with 95% O2 and 5% CO2, pH 7.4. After the extraction of the hippocampus, 400 μm-thick transverse slices were cut in ice-cold ACSF with a vibratome (Series 1000 plus starter CE, Vibratome, St. Louis, MO, USA) and allowed to recover in oxygenated ACSF at room temperature for 2 h before experimental recordings.
Field Potential Recordings
For each animal we used 2–3 slices. A slice was transferred into the recording chamber and submerged with ACSF at a constant rate of 2 ml/min at room temperature.
Extracellular recordings with borosilicate glass capillaries (GC150F-10; Harvard Apparatus) filled with 2M NaCl (resistance, 10–15 MΩ) were obtained from the apical dendritic layer of the CA1 region for analysis of population EPSPs. Synaptic responses were elicited by applying single stimuli pulses (duration: 20 μs and intensity: 20–50 mA) at a frequency of 0.05 Hz through a bipolar platinum-iridium stimulating electrode placed in the Schaffer collateral–commissural pathway. This stimulation evoked field EPSPs (fEPSPs) that were 50–70% of maximal slope. FEPSPs were filtered at 3 KHz, digitized at 10 KHz and stored on PC equipped with a data acquisition card (at-MIO-16E-2, National Instruments, Austin, TX, USA). An Axoclamp 2B amplifier (Molecular Devices, USA) was used for the recordings.
After a stable baseline recording for 20 min, LTD/DP or LTP was induced. For inducing LTD and DP we used a LFS protocol consisting of 15 min stimulation at 1 Hz applied at the same stimulus intensity. LTP was normally induced by HFS (a single 1 s-100 Hz tetanus) at the same stimulus intensity. In some experiments the LTP induction was investigated by using a single weak frequency stimulation (WFS, 1 s-25 Hz tetanus) or medium frequency stimulation (MFS, 1 s-50 Hz tetanus).
Drugs
E2 (0.5–1 nM), DHT (10–50 nM), T (50 nM), the specific inhibitor of the enzyme 5α-reductase finasteride (1 μM) (Finn et al., 2006) and the specific inhibitor of P450-aromatase enzyme letrozole (100 nM) (Bhatnagar et al., 2001) were used for the experiments. All drugs were purchased from Sigma-Aldrich (St Louis, MO, USA). Stock drug solutions were dissolved in DMSO, diluted to working concentration in oxygenated ACSF and perfused at a rate of 2 ml/min. Total replacement of the medium in the chamber occurred within 1 min. In the experiments in which the effect of LFS, HFS, WFS or MLF was analyzed in the presence of blocking agents, drugs were applied for all the recording period 15 min before the application of the stimulation protocol. The influence of drug vehicle (0.001% DMSO) on the induction of LTD/DP and LTP was excluded on the basis of analysis performed previously (Pettorossi et al., 2013).
Electrophysiological Data Analysis and Statistical Evaluation
To characterize the drug effects on the baseline fEPSP and on the induction of the long-term effects caused by different stimulation protocols, testing stimuli were applied every 20 s. The initial slope of fEPSP was measured using linear regression of the first 0.8 ms succeeding the pre-synaptic fiber volley and the average response recorded during a stable period (10 min) at the beginning of the experiment was used as the baseline. The averaged fEPSP, calculated every 2 min, was expressed as percentage of the baseline fEPSP value and used for data presentation. In each experiment, the occurrence of LTD or LTP was statistically verified (Student’s paired t test) by comparing the fEPSP slopes measured 40 min following the inducing stimulus relative to baseline responses. To prove the induction of DP (Staubli and Lynch, 1990; Dudek and Bear, 1993) we compared in each experiment (Student’s paired t test) the pre-LFS fEPSP values with those measured 40 min after LFS. In addition, the effects of drugs on the baseline were evaluated by comparing (Student’s paired t test) the pre-drug fEPSP values with those measured 10–15 min after the drug application. Moreover, the effects observed in different experimental conditions were compared by using the one-way analysis of variance (ANOVA) and the Tukey’s post hoc test. The level of significance was set at p < 0.05 for Student’s t test, ANOVA and post hoc comparisons. Statistical analyses were performed with Statistica (StatSoft, Tulsa, OK, USA). Values given in the text are mean ± SEM, n representing the number of the slices.
Results
Role of DHT and E2 Neo-Syntheses in the Development of LFS-LTD
Inhibition of 5α-Reductase by Finasteride Prevents the Development of LFS-LTD
In control condition LFS induced LTD of synaptic transmission reducing the fEPSP to 73.3 ± 3.4% (n = 9, 4 animals, Figures 1A,D). The application of finasteride did not change the baseline (pre-drug 100.6 ± 0.6% vs. post-drug 101.1 ± 0.4%, n = 8, 3 animals, Student’s t test, p = 0.51, Figure 1A), but it fully prevented LFS-LTD. A partial LTP was induced instead, since LFS enhanced the fEPSP to 148 ± 4.5% (n = 8, Figures 1A,D). This potentiation was significantly smaller than the LTP normally induced by HFS (Tukey’s post hoc test, LFS + FIN vs. HFS control: p < 0.001, Figure 1D). Moreover, finasteride applied following LFS-LTD induction had no effect (pre-drug 73.1 ± 4.6% vs. post-drug 73.7 ± 4.3%, n = 4, 2 animals, Student’s t test, p = 0.39, data not shown).
Exogenous DHT Rescues the LFS-LTD under 5α-Reductase Inhibition by Finasteride
Application of 50 nM DHT did not modify either the baseline (pre-drug 100.7 ± 0.5% vs. post-drug 99.7 ± 0.2%, n = 8, 3 animals, Student’s t test, p = 0.18, Figure 1A) or the development of LFS-LTD (70.5 ± 2.5%, n = 8, Tukey’s post hoc test, LFS + 50 nM DHT vs. LFS control: p = 0.99, Figures 1A,D), but it was able to fully rescue the LFS-LTD under finasteride (72.3 ± 2%, n = 8, 3 animals, Tukey’s post hoc test, LFS + FIN + 50 nM DHT vs. LFS control, p = 0.99, Figures 1B,D). Conversely, this rescue did not occurr using lower concentration of DHT (10 nM) since LFS still induced a partial LTP (150.5 ± 2.1%, n = 8, 3 animals, Figure 1B, Tukey’s post hoc test, LFS + FIN +10 nM DHT vs. LFS + FIN, p = 0.99, Figure 1D). In addition, we also applied 50 nM testosterone (T) under finasteride for rescuing LTD. T did not change the baseline (pre-drug 100.7 ± 0.4% vs. post-drug 100.6 ± 0.1%, n = 8, 3 animals, Student’s t test, p = 0.87, Figure 1B) and was not able to rescue the LFS-LTD since a partial LTP was induced, not different from that observed under finasteride alone (150.7 ± 2.8%, n = 8, Tukey’s post hoc test, LFS + FIN +50 nM T vs. LFS + FIN: p = 0.99, Figures 1B,D).
Overall, these results on blockade of 5α-reductase provide evidence that the DHT synthesized de-novo plays a crucial role in the development of LFS-LTD, while T has no effect.
Inhibition of P450-Aromatase by Letrozole does not Affect the Development of LFS-LTD
Letrozole did not affect either the baseline (pre-drug 100.2 ± 0.2% vs. post-drug 100.7 ± 0.4%, n = 8, 3 animals, Student’s t test, p = 0.43, Figure 1C) or the development of LFS-LTD (74.8 ± 5%, n = 8, Tukey’s post hoc test, LFS + LET vs. LFS control, p = 0.99, Figures 1C,D). In addition, the partial LTP observed under fiansteride was not modified when LFS was delivered under letrozole plus finasteride (152.7 ± 4.3%, n = 8, 3 animals, Tukey’s post hoc test, LFS + FIN + LET vs. LFS + FIN, p = 0.98, Figures 1C,D). These data suggest that E2 neo-synthesis is not implied in the development of either LFS-LTD or LFS-small LTP.
Exogenous E2 Reverts LFS-LTD into LFS-LTP
In agreement with earlier reports (Foy et al., 1999; Bi et al., 2001; Kramár et al., 2009), infusion of 1 nM E2 caused a rapid increase of the fEPSP baseline (139.4 ± 5.1%, n = 8, 4 animals, Figure 2A). Subsequent application of LFS elicited LTP (193.9 ± 5.3%, n = 8, Figure 2A) that persisted at the E2 washout (195.1 ± 5.5%, Student’s t test, p = 0.42) and was not different from the LTP induced by HFS (Tukey’s post hoc test, LFS + 1 nM E2 vs. HFS control, p = 0.97, Figure 2B). The same effect was observed when LFS was delivered under E2 after adjusting the stimulation pulse strength (asE2) to produce responses equivalent in size to those recorded during pre-infusion baseline (LTP: 197.8 ± 3.2%, n = 8, 3 animals, Tukey’s post hoc test, LFS + 1 nM asE2 vs. LFS + 1 nM E2, p = 0.87, LFS + 1 nM as E2 vs. HFS control, p = 0.99, Figures 2A,B). E2 used at lower concentration (0.5 nM) also increased the baseline (142.4 ± 3%, n = 8, 3 animals) similarly to what observed after 1 nM E2 (ANOVA: F(1, 14) = 0.25; p = 0.68, Figure 2A). LFS delivered after adjusting the response to the pre-drug values induced LTP (174.5 ± 2.2%, n = 8, Figure 2A) that was lower than the one obtained in the presence of 1 nM asE2 (Tukey’s post hoc test: LFS + 0.5 nM asE2 vs. LFS + 1 nM asE2, p < 0.05, Figures 2A,B).
This result demonstrates that exogenously administered E2 is able to revert the LTD induced by LFS into LTP.
Role of E2 and DHT Neo-Synthesis in the Development of LTP Depotentiation
Inhibition of 5α-Reductase by Finasteride Prevents the LFS-DP
In control condition HFS induced LTP (193.4 ± 3.5%, n = 9, 4 animals) and LFS delivered 30 min after induced DP reducing LTP to 147.8 ± 8% (n = 9, Student’s t test, p = 0.003; Figure 3). Application of finasteride starting 15 min after HFS had no effect on the already settled LTP (pre-drug 192.4 ± 5.7% vs. post-drug 194.1 ± 5.8%, n = 8, 4 animals, Student’s t test, p = 0.85, Figures 3A,B), but it prevented the LFS-DP (pre-LFS 194.1 ± 5.8% vs. post-LFS 194.5 ± 5.3%, n = 8, Student’s t test, p = 0.82, Figures 3A,B,D).
Administration of 50 nM DHT under finasteride did not affect the induced LTP (pre-drug 194.1 ± 3.1% vs. post-drug 194.6 ± 3.5%, n = 8, 3 animals, Student’s t test, p = 0.8, Figure 3A), but it was able to rescue the LFS-DP (pre-LFS 194.6 ± 3.9% vs. post-LFS 140 ± 1.9%, n = 8, Student’s t test, p < 0.0001; Tukey’s post hoc test: LFS + DHT + FIN vs. LFS control, p = 0.99, Figures 3A,D). On the whole, this result provides evidence that the DHT neo-synthesis plays a crucial role in the development of LFS-DP.
Inhibition of P450-Aromatase by Letrozole does not Affect the Development of LFS-DP
We also assayed the effects of letrozole alone and finasteride plus letrozole on the induction of LFS-DP. Letrozole did not modify the LTP once induced by HFS (pre-drug 193.8 ± 6.1% vs. post-drug 191.9 ± 5.8%, n = 8, 3 animals, Student’s t test, p = 0.37, Figure 3B), or the DP after LFS (pre-LFS 191.9 ± 5.8% vs. post-LFS 139.1 ± 6.4%, n = 8, Student’s t test, p < 0.001, Figure 3B, Tukey’s post hoc test: LFS + LET vs. LFS control, p = 0.99, Figure 3D) and it did not rescue the DP when suppressed by finasteride (pre-LFS 192.7 ± 6.6% vs. post-LFS 194.5 ± 6%, n = 8, 3 animals, Student’s t test, p = 0.61, Figures 3B,D). Like observed for the LFS-LTD, these results further exclude a role of E2 neo-synthesis in the depressant effects induced by LFS.
Exogenous E2 Prevents the LFS-DP
We assayed whether exogenous E2 influenced the induction of LFS-DP. Application of 1 nM E2 starting 15 min after the induction of HFS-LTP had no effect on LTP (pre-drug 196.2 ± 9.6% vs. post-drug 195.6 ± 7.8%, n = 8, 3 animals, Student’s t test, p = 0.82, Figure 3C), but it prevented the LFS-DP (pre-LFS 195.6 ± 7.8% vs. post-LFS 195.6 ± 8.7%, n = 8, Student’s t test, p = 0.98, Figures 3C,D). This finding demonstrates that although the E2 neo-synthesis does not play any role in the LFS-DP, exogenous E2 is able to prevent it.
Role of E2 and DHT Neo-Synthesis in the Development of HFS-LTP
Effect of P450-Aromatase and 5α-Reductase Blockade on the Development of HFS-LTP
In full agreement with our previous results (Grassi et al., 2011), HFS in the presence of letrozole induced LTP (129 ± 4.3%, n = 10, 4 animals, Figures 4A,B) that was significantly smaller than that obtained in the control condition (199.8 ± 7%, n = 17, 6 animals, Tukey’s post hoc test: HFS + LET vs. HFS control, p < 0.001, Figure 4D). By contrast, LTP induced under finasteride was markedly enhanced (296.5 ± 9.1%, n = 8, 3 animals, Tukey’s post hoc test: HFS + FIN vs. HFS control, p < 0.001, Figures 4A,D). In addition, the combined application of finasteride and letrozole caused LTP (165.3 ± 2.2%, n = 8, 3 animals, Figure 4A) of an amplitude that was in-between the control LTP and LTP under letrozole alone (Tukey’s post hoc test: HFS + LET + FIN vs. HFS control, p < 0.01, HFS + LET + FIN vs. HFS + LET, p < 0.01, Figures 4A,D).
These results demonstrate that the blockade of E2 and DHT synthesis remarkably alters the response to HFS by decreasing or increasing the amplitude of LTP, respectively.
Exogenous E2 Rescues LTP When HFS is Delivered Under the P450-Aromatase Inhibitor Letrozole
Application of exogenous 1 nM E2 increased the baseline fEPSP (136.1 ± 3.4%, n = 8, 3 animals, Figure 4B) and the HFS-LTP to 227.8 ± 3.2% (n = 8, Figure 4B) a value that was higher than that observed in the control condition (Tukey’s post hoc test: HFS+1 nM E2 vs. HFS control, p < 0.05, Figure 4E). This enhancement of LTP was observed after reducing the stimulus intensity to cancel the baseline increase.
Similarly, application of 1 nM E2 in the presence of letrozole enhanced the baseline (135.2 ± 3.8%, n = 8, 4 animals, Figure 4B) and rescued the HFS-LTP to a value (233.8 ± 7.3%, n = 8) that was not different from that observed after HFS under E2 alone (Tukey’s post hoc test: HFS + LET + 1 nM E2 vs. HFS + 1 nM E2, p = 0.98, HFS + LET + 1 nM E2 vs. HFS + LET, p < 0.001, Figures 4B,E). In addition, no difference was observed by using E2 at lower concentration (0.5 nM), either on the baseline (135.2 ± 2.4%, n = 8, 3 animals, Figure 4B) or on the HFS-LTP (239.6 ± 2.8%, n = 8, Tukey’s post hoc test: LET + 0.5 nM E2 vs. LET + 1 nM E2, p = 0.98, Figures 4B,E).
Exogenous DHT does not Influence the HFS-LTP
We verified whether exogenous DHT might influence the development of LTP by delivering HFS in the presence of 50 nM DHT. DHT did not interfere with the HFS-LTP (194.7 ± 4.2%, n = 8, 3 animals, Tukey’s post hoc test: HFS + 50 nM DHT vs. HFS control, p = 0.99, Figures 4C,E).
Different Involvement of DHT and E2 Neo-Synthesis in LTP Induced by WFS and MFS
By using WFS (1 s-25 Hz) a very small LTP was induced (114.8 ± 2.2%, n = 8, 4 animals, Figure 5A) compared with that induced by HFS (Tukey’s post hoc test: WFS control vs. HFS control, p < 0.001, Figure 5B). The contribution of the neo-synthesis of DHT and/or E2 in the induction of this small LTP was examined by applying finasteride, letrozole or finasteride plus letrozole. In the presence of finasteride WFS induced a robust LTP (157.4 ± 5.9%, n = 8, 3 animals, Tukey’s post hoc test: WFS + FIN vs. WFS control, p < 0.001, Figures 5A,B), while in the presence of letrozole LTP was not different from the control one (113.7 ± 2%, n = 8, 3 animals, Tukey’s post hoc test: WFS + LET vs. WFS control, p = 0.99, WFS + LET vs. WFS + FIN, p < 0.001, Figures 5A,B). The addition of letrozole to finasteride did not modify the amplitude of LTP compared to that induced under finasteride alone (162 ± 4.2%, n = 8, 3 animals, Tukey’s post hoc test: WFS + FIN + LET vs. WFS + FIN, p = 0.98, WFS + FIN + LET vs. WFS + LET, p < 0.001, WFS + FIN + LET vs. WFS control, p < 0.001, Figures 5A,B). Conversely, MLF (1 s-50 Hz) induced LTP (196.8 ± 7.4%, n = 8, 4 animals, Figure 5C) that was not different from that induced by HFS (Tukey’s post hoc test: MFS control vs. HFS control, p = 0.99, Figure 5D). This LTP was significantly reduced in the presence of letrozole (127.9 ± 1.6%, n = 8, 3 animals, Tukey’s post hoc test: MFS + LET vs. MFS control, p < 0.001, Figures 5C,D), but it was not changed under finasteride (201.3 ± 7.7%, n = 8, 3 animals, Tukey’s post hoc test: MFS + FIN vs. MFS control, p = 0.95, Figures 5C,D). In addition, under combined application of letrozole and finasteride the amplitude of MLF-LTP (165.2 ± 2.4, n = 8, 3 animals, Figure 5C) was in-between the control and letrozole values (Tukey’s post hoc test: MFS + FIN + LET vs. MFS control, p < 0.05, MFS + FIN + LET vs. MFS + LET, p < 0.01, Figure 5D). These results suggest that for the WFS long-term response the synthesis of DHT is involved, whereas E2 does not play any role. Conversely, the synthesis of E2 is only required for the development of a full LTP by MFS.
Comparison of the Responses Observed Under Blockade of E2 (Letrozole) and E2 Plus DHT (Letrozole Plus Finasteride) Syntheses Across Different Stimulation Protocols
The partial LTPs observed under combined blockade of E2 and DHT synthesis were compared across all different stimulus protocols (LFS, MFS, WFS and HFS). A small enhancement of LTP amplitude appeared at higher frequencies, but the differences were significant only between LFS-LTP and LTP induced by MFS and HFS (Tukey’s post hoc test: LFS vs. WFS, p = 0.1, LFS vs. MFS, p < 0.05, LFS vs. HFS, p < 0.05, WFS vs. MFS, p = 0.93, WFS vs. HFS, p = 0.83, MFS vs. HFS, p = 0.99, Figure 6). Moreover, the responses under blockade of E2 synthesis alone significantly changed passing from full LTD by LFS to an increasing LTP at WFS, MFS and HFS (Tukey’s post hoc test: LFS vs. WFS, p < 0.001, LFS vs. MFS, p < 0.001, LFS vs. HFS, p < 0.001, WFS vs. MFS, p < 0.05, WFS vs. HFS, p < 0.05, MFS vs. HFS, p = 0.99, Figure 6).
The comparison of the responses observed under combined and single block across all stimulation patterns allows the evaluation of the inhibitory effect of the DHT at different stimulation frequencies. The DHT inhibition was indeed computable by subtracting the amplitude of the responses under letrozole from that under finasteride plus letrozole. The inhibitory influence, as resulting from this computation, was present throughout all stimulus patterns, but diminished progressively by increasing the stimulus frequency (LFS: 77.8%, WFS: 48.3%, MFS: 37.3%, HFS: 36.3%, Figure 6). In fact, the amplitude of responses under letrozole significantly increased showing a large change passing from LFS to HFS, while the partial LTP obtained under combined block of E2 and DHT showed a minor change that was significant only between LFS and MFS or HFS (Figure 6).
Discussion
This study demonstrates that the neo-syntheses of DHT and E2 during synaptic stimulation are crucial for the development and the sign of the long-term synaptic modification in the hippocampus CA1 region of male rat. In fact, the LTD and DP induced by LFS were prevented by finasteride, a blocking agent for the 5α-reductase enzyme converting T into DHT, while LTP induced by HFS was markedly reduced by letrozole, an inhibitor of the P450-aromatase mediating conversion of T into E2.
About the long-term effects of LFS, LTD induced in naïve neurons was fully prevented by finasteride, and a small LTP, instead, was evoked (Figure 7A). In addition, finasteride precluded the LFS-DP in neurons previously potentiated by HFS. The role of DHT synthesis was confirmed by the rescue of LTD and DP yielded by high concentration (50 nM) of DHT administered in the presence of finasteride, while lower concentration (10 nM) was inefficacious.
Considering that the basal synaptic activity was not influenced by exogenous DHT, we conclude that the block of DHT neo-synthesis definitely affects LTD and DP by interacting with their induction mechanism. Conversely, the synthesis of DHT was not implied in the maintenance of LTD since finasteride did not modify LTD, once settled.
Actually, the 5α-reductase is also implied in the synthesis of other neurosteroids, like the tetrahydrodeoxycorticosterone (THDOC) and allopregnanolone (ALLO) that are facilitatory allosteric modulators of GABAA receptors (Lambert et al., 2003; Reddy, 2003). However, the androgenic neurosteroids have certainly a determinant role in the induction of LTD and DP since these long-term synaptic changes produced by LFS were also fully prevented by the blockade of ARs (Pettorossi et al., 2013). For the same reason, we exclude the influence of the DHT metabolites such as Adiol, which is reported to interfere with GABAA-mediated GABAergic transmission (Frye et al., 2001; Edinger et al., 2004; Reddy, 2004; Reddy and Jian, 2010).
Conversely, since ARs can bind both DHT and T, the involvement of T in LTD might be proposed. However, the finding that exogenously administered T, differently from DHT, was not able to rescue the LTD under finasteride, excludes T participation. To justify this diverse influence we took into account the lower receptor affinity of T compared with DHT (Zhou et al., 1995; Fang et al., 2003), which might also explain why the upstream accumulation of T, occurring under block of DHT synthesis, was not able to substitute for the lack of DHT.
We also examined the possible role of the neo-synthesis of E2 in the LFS depressive responses by applying letrozole. Both LFS-LTD and DP were not affected by letrozole, suggesting that E2 has no influence in the induction of these phenomena. In addition, under letrozole, we did not observe any enhancement of LTD and DP, as expected in the case of increase of DHT synthesis due to upstream accumulation of T. This suggests that the DHT-dependent LFS effects are not influenced by additional DHT, as also supported by the inability of exogenous DHT to modify the LFS-LTD.
Although E2 is not implied in the LFS-LTD, administration of E2 was indeed able to revert LTD into a robust LTP (Figure 7A). This suggests that the plastic events induced by LFS may be influenced by E2, but this influence is not normally possible due to a too low level of basally synthesized E2 and/or the stimulus inability to increase it. Unlike LTD and DP, E2 neo-synthesis is relevant for the full induction of the LTP (Grassi et al., 2011; Tanaka and Sokabe, 2012; Figure 7B), while it does not influence LTP maintenance (Grassi et al., 2011). Here, we found that under blockade of P450-aromatase the application of 1 or 0.5 nM E2 fully rescued LTP, enhancing its amplitude to values even higher than the control one. This rescue was not due to normal increase of the baseline induced by exogenous E2 since similar LTP was observed after lowering the stimulus intensity to recover the pre-E2 baseline.
Another point of interest concerns the role of DHT in HFS-LTP. Blockade of DHT synthesis during HFS induced a remarkable enhancement of the LTP amplitude. Is this evidence for a persistent influence of an inhibitory role of DHT at HFS, or is it the result of enhanced synthesis of E2 due to upstream accumulation of T? The fact that, differently from finasteride, AR antagonism did not change the amplitude of HFS-LTP (Pettorossi et al., 2013) straightforwardly supports the effect of T accumulation. However, the LTP obtained under combined block of E2 and DHT synthesis was higher than that observed under letrozole alone, suggesting the presence of an inhibitory DHT influence. It is likely that this influence is prevented or masked when the E2 synthesis is allowed (Figure 7B).
The contribution of E2 and DHT has been also examined on the responses induced by intermediate stimulation frequencies: WFS (1 s-25 Hz) and MFS (1 s-50 Hz). WFS elicited a small LTP that was enhanced by finasteride, but unaffected by letrozole, as occurs for the LFS-LTD. Conversely, MFS elicited a LTP that was similar to that induced by HFS and similarly was reduced by letrozole, but, at variance, not enhanced by finasteride.
This different effect might be due to the inability of MFS to drive a further synthesis of E2 from the T accumulated following the block of DHT synthesis. These results support the idea of a frequency dependent T-E2 conversion that is less powerful or null at lower frequencies.
On the whole, a basal partial LTP is only inducible, independently of stimulation pattern (LFS, WFS, MFS and HFS), under combined blockade of E2 and DHT synthesis. It is, in fact, the synthesis of E2 responsible for the enhancement of this basal LTP to a full LTP following MFS and HFS, and that of DHT that reverts the LTP into LTD following LFS. In contrast, with the influence of E2 that is only limited to the range of higher stimulation frequencies, DHT is maximally operative in the range of low frequencies, but its effect persists, even if with minor extent, across all tested frequencies. The amount of the DHT effect is detectable by computing the difference between the amplitude of LTP under combined blocks and under block of E2 synthesis alone.
The reason for a frequency dependent differential effect of E2 and DHT might be related to the specific interaction between the stimulus frequency and the basally synthesized neurosteroids, or to a specific capability of the stimulation patterns to increase neurosteroid synthesis depending on their frequency (Figure 7).
The frequency dependent activation of P450-aromatase and 5α-reductase on synaptic transmission is conceivable since different levels of Ca2+ entry modulated by the nervous activity (Kimoto et al., 2001; Balthazart and Ball, 2006; Hojo et al., 2008) may influence the enzymatic function. It is known, in fact, that LTP or LTD is driven by different velocity and amount of NMDAR-mediated Ca2+ increase (Dudek and Bear, 1992; Bear and Malenka, 1994; Cummings et al., 1996). In line with this evidence, we suggest that while DHT synthesis, even if it seems to be activated by a broad range of frequencies, is mostly enhanced by low frequency inducing a low Ca2+ entry (Dudek and Bear, 1992; Bear and Malenka, 1994; Cummings et al., 1996), E2 synthesis is triggered by HFS inducing high Ca2+ entry. However, the possible enzymatic activation of P450-aromatase by high Ca2+ entry is in contrast with data in the literature. In fact, a rapid inhibition of P450-aromatase, via a Ca2+-dependent phosphorylation, has been evidenced following increases of intracellular Ca2+ due to K+-induced depolarization or activation of glutamatergic receptors (Balthazart et al., 2001, 2003, 2006; Charlier et al., 2015). This prompts for a reduction of E2 synthesis during HFS. Conversely, our study suggests that the increase of E2 neo-synthesis should be driven by HFS, while increase of DHT neo-synthesis by LFS. To overcome this divergence, we propose that the velocity of Ca2+ entry following synaptic activation is a crucial point influencing differently phosphorilation-dephosphorilation processes for activating P450-aromatase or 5α-reductase enzymes.
Concerning the mechanisms through which new synthesized estrogenic and androgenic neurosteroids lead to long-term synaptic changes, we suggest that the activation of ERs and ARs might produce a functional up- or down-regulation of the NMDARs, respectively (Pouliot et al., 1996; Foy et al., 1999; Smith and McMahon, 2005, 2006; Grassi et al., 2010) and influence the GABAergic neurotransmission in opposite ways, by interacting with the GABARs (Murphy et al., 1998; Frye et al., 2001; Rudick and Wooley, 2001; Edinger et al., 2004).
The influence of androgenic and estrogenic signals is probably exerted at postsynaptic level, as blockade of either ARs or ERs did not affect the facilitated responses to paired stimuli (Pettorossi et al., 2013).
Despite the need of further insight of the site and mechanism of neurosteroids in the synaptic plasticity, the current study puts forward a crucial function of neo-synthesized E2 and DHT in the induction and direction of the hippocampal synaptic plasticity.
Since our study has been performed only in male rat, we should be cautious in generalizing these mechanisms as it may vary depending on sex, estrous cycle and age, as shown in the vestibular system (Pettorossi et al., 2011; Grassi et al., 2012).
However, in this work we definitely demonstrated that specific stimulation patterns within the CNS are able to determine the amplitude and the sign of long-term synaptic effects through the neo-synthesis of E2 or DHT. Neural E2 and DHT should thus be recognized as very effective central modulators of synaptic plasticity that may significantly contribute to learning and memory performance.
Author Contributions
The experiments were performed in the laboratory of SG at the University of Perugia. VEP, SG and PC designed the experiments and wrote the manuscript; MDM and AT performed and analyzed the experiments. All authors provided important intellectual content and critically revised the final version of the manuscript.
Funding
This work was supported by grants from Progetto di Ricerca di Interesse Nazionale (PRIN) 2010-2011 AHHP5H to PC and SG and Fondazione Cassa di Risparmio di Perugia (2009.020.0036 to PC and VEP and 2014-0104 to AT).
Conflict of Interest Statement
PC is a member of the editorial boards of Lancet Neurology, Journal of Neuroscience, Movement Disorders, and Synapse and receives research support from Biogen, Lundbeck, Merck-Serono, Sanofi-Aventis, UCB, Fondazione Santa Lucia IRCCS and Ministero della Salute. The other authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Acknowledgments
We thank Mr. E. Mezzasoma and Mr. M. Roscini for technical assistance.
Glossary
Abbreviations
- ARs
androgen receptors
- DHT
5α-dihydrotestosterone
- DP
depotentiation
- E2
17b-estradiol
- ERs
estrogen receptors
- fEPSP
field excitatory postsynaptic potential
- FIN
finasteride
- HFS
high frequency stimulation
- LET
letrozole
- LFS
low frequency stimulation
- LTD
long-term depression
- LTP
long-term potentiation
- MFS
medium frequency stimulation
- NMDAR
NMDA receptors
- T
testosterone
- WFS
weak frequency stimulation.
References
- Balthazart J., Ball G. F. (2006). Is brain estradiol a hormone or a neurotransmitter? Trends Neurosci. 29, 241–249. 10.1016/j.tins.2006.03.004 [DOI] [PubMed] [Google Scholar]
- Balthazart J., Baillien M., Ball G. F. (2001). Phosphorylation processes mediate rapid changes of brain aromatase activity. J. Steroid Biochem. Mol. Biol. 79, 261–277. Neuroendocrinol.26, 63–73. 10.1016/s0960-0760(01)00143-1 [DOI] [PubMed] [Google Scholar]
- Balthazart J., Baillien M., Ball G. F. (2006). Rapid control of brain aromatase activity by glutamatergic inputs. Endocrinology 147, 359–366. 10.1210/en.2005-0845 [DOI] [PubMed] [Google Scholar]
- Balthazart J., Baillien M., Charlier T. D., Ball G. F. (2003). Calcium-dependent phosphorylation processes control brain aromatase in quail. Eur. J. Neurosci. 17, 1591–1606. 10.1046/j.1460-9568.2003.02598.x [DOI] [PubMed] [Google Scholar]
- Baulieu E. E. (1997). Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Rec. Prog. Horm. Res. 52, 1–32. [PubMed] [Google Scholar]
- Bear M. F., Malenka R. C. (1994). Synaptic plasticity: LTP and LTD. Curr. Opin. Neurobiol. 4, 389–399. 10.1016/0959-4388(94)90101-5 [DOI] [PubMed] [Google Scholar]
- Bhatnagar A. S., Brodie A. M. H., Long B. J., Evans D. B., Miller W. R. (2001). Intracellular aromatase and its relevance to the pharmacological efficacy of aromatase inhibitors. J. Steroid Biochem. Mol. Biol. 76, 199–202. 10.1016/s0960-0760(01)00050-4 [DOI] [PubMed] [Google Scholar]
- Bi R., Foy M. R., Vouimba R. M., Thompson R. F., Baudry M. (2001). Cyclic changes in estradiol regulate synaptic plasticity through the MAP kinase pathway. Proc. Natl. Acad. Sci. U S A 98, 13391–13395. 10.1073/pnas.241507698 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bliss T. V. P., Collingridge G. L. (1993). A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31–39. 10.1038/361031a0 [DOI] [PubMed] [Google Scholar]
- Bliss T. V. P., Lomo T. (1973). Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J. Physiol. 232, 331–356. 10.1113/jphysiol.1973.sp010273 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Charlier T. D., Cornil C. A., Patte-Mensah C., Meyer L., Mensah-Nyagan A. G., Balthazar J. (2015). Local modulation of steroid action: rapid control of enzymatic activity. Front. Neurosci. 9:83. 10.3389/fnins.2015.00083 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Compagnone N. A., Mellon S. H. (2000). Neurosteroids: biosynthesis and function of these novel neuromodulators. Front. Neuroendocrinol. 21, 1–56. 10.1006/frne.1999.0188 [DOI] [PubMed] [Google Scholar]
- Cummings J. A., Mulkey R. M., Nicoll R. A., Malenka R. C. (1996). Ca2+ signalling requirements for long-term depression in the hippocampus. Neuron 16, 825–833. 10.1016/s0896-6273(00)80102-6 [DOI] [PubMed] [Google Scholar]
- Dudek S. M., Bear M. F. (1992). Homosynaptic long-term depression in area CA1 of hippocampus and effects of N-methyl-D-aspartate receptor blockade. Proc. Natl. Acad. Sci. U S A 89, 4363–4367. 10.1073/pnas.89.10.4363 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dudek S. M., Bear M. F. (1993). Bidirectional long-term modification of synaptic effectiveness in the adult and immature hippocampus. J. Neurosci. 13, 2910–2918. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Edinger K. L., Lee B., Frye C. A. (2004). Mnemonic effects of testosterone and its 5α-reduced metabolites in the conditioned fear and inhibitory avoidance tasks. Pharmacol. Biochem. Behav. 78, 559–568. 10.1016/j.pbb.2004.04.024 [DOI] [PubMed] [Google Scholar]
- Fang H., Tong W., Branham W. S., Moland C. L., Dial S. L., Hong H., et al. (2003). Study of 202 natural, synthetic and environmental chemicals for binding to the androgen receptor. Chem. Res. Toxicol. 16, 1338–1358. 10.1021/tx030011g [DOI] [PubMed] [Google Scholar]
- Finn D. A., Beadles-Bohling A. S., Beckley E. H., Ford M. M., Gilliland K. R., Gorin-Mneyer R. E., et al. (2006). A new look at the 5alpha-reductase inhibitor finasteride. CNS Drug Rev. 12, 53–76. 10.1111/j.1527-3458.2006.00053.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- Foradori C. D., Weiser M. J., Handa R. J. (2008). Non-genomic actions of androgens. Front. Neuroendocrinol. 29, 169–181. 10.1016/j.yfrne.2007.10.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Foy M. R. (2001). 17beta-estradiol: effects on CA1 hippocampal synaptic plasticity. Neurobiol. Learn. Mem. 76, 239–252. 10.1006/nlme.2001.4018 [DOI] [PubMed] [Google Scholar]
- Foy M. R., Xu J., Xie X., Brinton R. D., Thompson R. F., Berger T. W. (1999). 17beta-Estradiol enhances NMDA receptor-mediated EPSPs and long-term potentiation. J. Neurophysiol. 81, 925–929. [DOI] [PubMed] [Google Scholar]
- Frye C. A., Park D., Tanaka M., Rosellini R., Svare B. (2001). The testosterone metabolite and neurosteroid 3alpha-androstanediol may mediate the effects of testosterone on conditioned place preference. Psychoneuroendocrinology 26, 731–750. 10.1016/s0306-4530(01)00027-0 [DOI] [PubMed] [Google Scholar]
- Good M., Day M., Muir J. L. (1999). Cyclical changes in endogenous levels of oestrogen modulate the induction of LTD and LTP in the hippocampal CA1 region. Eur. J. Neurosci. 11, 4476–4480. 10.1046/j.1460-9568.1999.00920.x [DOI] [PubMed] [Google Scholar]
- Grassi S., Frondaroli A., Dieni C., Scarduzio M., Pettorossi V. E. (2009). Long-term potentiation in the rat medial vestibular nuclei depends on locally synthesised 17beta-Estradiol. J. Neurosci. 29, 10779–10783. 10.1523/JNEUROSCI.1697-09.2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Grassi S., Frondaroli A., Scarduzio M., Dieni C. V., Brecchia G., Boiti C., et al. (2012). Influence of sex and estrous cycle on synaptic responses of the medial vestibular nuclei in rats: role of circulating 17β-estradiol. Brain Res. Bull. 87, 319–327. 10.1016/j.brainresbull.2011.11.008 [DOI] [PubMed] [Google Scholar]
- Grassi S., Frondaroli A., Scarduzio M., Dutia B., Dieni C., Pettorossi V. E. (2010). Effects of 17b-estradiol on glutamate synaptic transmission and neuronal excitability in the rat medial vestibular nuclei. Neuroscience 165, 1100–1114. 10.1016/j.neuroscience.2009.11.039 [DOI] [PubMed] [Google Scholar]
- Grassi S., Tozzi A., Costa C., Tantucci M., Colcelli E., Scarduzio M., et al. (2011). Neural 17beta-Estradiol facilitates long-term potentiation in the hippocampal CA1 region. Neuroscience 192, 67–73. 10.1016/j.neuroscience.2011.06.078 [DOI] [PubMed] [Google Scholar]
- Hajszan T., MacLusky N. J., Leranth C. (2008). Role of androgens and the androgen receptor in remodeling of spine synapses in limbic brain areas. Horm. Behav. 53, 638–646. 10.1016/j.yhbeh.2007.12.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Harley C. W., Malsbury C. W., Squires A., Brown R. A. M. (2000). Testosterone decreases CA1 plasticity in vivo in gonadectomized male rats. Hippocampus 10, 693–696. [DOI] [PubMed] [Google Scholar]
- Hasegawa Y., Hojo Y., Kojima H., Ikeda M., Hotta K., Sato R., et al. (2015). Estradiol rapidly modulates synaptic plasticity of hippocampal neurons: involvement of kinase networks. Brain Res. 1621, 147–161. 10.1016/j.brainres.2014.12.056 [DOI] [PubMed] [Google Scholar]
- Hebbard P. C., King R. R., Malsury C. W., Harley C. W. (2003). Two organizational effects of pubertal testosterone in male rats: transient social memory and a shift away from long-term potentiation following a tetanus in hippocampal CA1. Exp. Neurol. 182, 470–475. 10.1016/s0014-4886(03)00119-5 [DOI] [PubMed] [Google Scholar]
- Hojo Y., Hattori T. A., Enami T., Furukawa A., Suzuki K., Ishii H. T., et al. (2004). Adult male rat hippocampus synthesizes estradiol from pregnenolone by cytochromes P450 17alpha and P450 aromatase localized in neurons. Proc. Natl. Acad. Sci. U S A 101, 865–870. 10.1073/pnas.2630225100 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hojo Y., Higo S., Ishii H., Ooishi Y., Mukai H., Murakami G., et al. (2009). Comparison between hippocampus-synthesized and circulation-derived sex steroids in the hippocampus. Endocrinology 150, 5106–5112. 10.1210/en.2009-0305 [DOI] [PubMed] [Google Scholar]
- Hojo Y., Murakami G., Mukai H., Higo S., Hatanaka Y., Ikeda M. O., et al. (2008). Estrogen synthesis in the brain. Role on synaptic plasticity and memory. Mol. Cell. Endocrinol. 290, 31–43. 10.1016/j.mce.2008.04.017 [DOI] [PubMed] [Google Scholar]
- Isgor C., Sengelaub D. R. (2003). Effects of neonatal gonadal steroids on adult CA3 pyramidal neuron dendritic morphology and spatial memory in rats. J. Neurobiol. 55, 179–190. 10.1002/neu.10200 [DOI] [PubMed] [Google Scholar]
- Kalita K., Szymczak S., Kaczmarek L. (2005). Non-nuclear estrogen receptor beta and alpha in the hippocampus of male and female rats. Hippocampus 15, 404–412. 10.1002/hipo.20066 [DOI] [PubMed] [Google Scholar]
- Kerr J. E., Allore R. J., Bech S. G., Hande R. J. (1995). Distribution and hormonal-regulation of androgen receptor (AR) and AR messenger ribonucleic acid in the rat hippocampus. Endocrinology 136, 3213–3221. 10.1210/en.136.8.3213 [DOI] [PubMed] [Google Scholar]
- Kimoto T., Tsurugizawa T., Ohta Y., Makino J., Tamura H., Hojo Y., et al. (2001). Neurosteroid synthesis by citochrome p450-containing systems localized in the rat brain. Endocrinology 142, 3578–3589. 10.1210/en.142.8.3578 [DOI] [PubMed] [Google Scholar]
- Kramár E. A., Chen L. Y., Brandon N. J., Rex C. S., Liu F., Gall C. M., et al. (2009). Cytoskeletal changes underline estrogen’s acute effects on synaptic transmission and plasticity. J. Neurosci. 29, 12982–12993. 10.1523/JNEUROSCI.3059-09.2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lambert J. J., Belelli D., Peden D. R., Vardy A. W., Peters J. A. (2003). Neurosteroids modulation of GABAA receptors. Prog. Neurobiol. 71, 67–80. 10.1016/j.pneurobio.2003.09.001 [DOI] [PubMed] [Google Scholar]
- Levin E. R. (2009). Plasma membrane estrogen receptors. Trends Endocrinol. Metab. 20, 477–482. 10.1016/j.tem.2009.06.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- MacLusky N. J., Hajszan T., Prange-Kiel J., Leranth C. (2006). Androgen modulation of hippocampal synaptic plasticity. Neuroscience 138, 957–965. 10.1016/j.neuroscience.2005.12.054 [DOI] [PubMed] [Google Scholar]
- Malenka R. C., Bear M. F. (2004). LTP and LTD: an embarrassment of riches. Neuron 44, 5–21. 10.1016/j.neuron.2004.09.012 [DOI] [PubMed] [Google Scholar]
- Malenka R. C., Nicoll R. A. (1999). Neuroscience-Long-term potentiation-a decade of progress? Science 285, 1870–1874. 10.1126/science.285.5435.1870 [DOI] [PubMed] [Google Scholar]
- Martin S. J., Grimwood P. D., Morris R. G. (2000). Synaptic plasticity and memory: an evaluation of the hypothesis. Annu. Rev. Neurosci. 23, 649–711. 10.1146/annurev.neuro.23.1.649 [DOI] [PubMed] [Google Scholar]
- McEwen B. S. (2002). Estrogen actions throughout the brain. Recent Prog. Horm. Res. 57, 357–384. 10.1210/rp.57.1.357 [DOI] [PubMed] [Google Scholar]
- Milner T. A., Ayoola K., Drake C. T., Herrick S. P., Tabori N. E., McEwen B. S., et al. (2005). Ultrastructural localization of estrogen receptor beta immunoreactivity in the rat hippocampal formation. J. Comp. Neurol. 491, 81–95. 10.1002/cne.20724 [DOI] [PubMed] [Google Scholar]
- Milner T. A., McEwen B. S., Hayashi S., Li C. J., Reagan L. P., Alves S. E. (2001). Ultrastructural evidence that hippocampal alpha estrogen receptors are located at extranuclear sites. J. Comp. Neurol. 429, 355–371. [DOI] [PubMed] [Google Scholar]
- Morissette M., Le Saux M., D’Astous M., Jourdain S., Al Sweidi S., Morin N., et al. (2008). Contribution of estrogen receptors alpha and beta to the effects of estradiol in the brain. J. Steroid Biochem. Mol. Biol. 108, 327–338. 10.1016/j.jsbmb.2007.09.011 [DOI] [PubMed] [Google Scholar]
- Mukai H., Takata N., Ishii H. T., Tanabe N., Hojo J., Furukawa A., et al. (2006). Hippocampal synthesis of estrogens androgens which are paracrine modulators of synaptic plasticity: synaptocrinology. Neuroscience 138, 757–764. 10.1016/j.neuroscience.2005.09.010 [DOI] [PubMed] [Google Scholar]
- Mulkey R. M., Malenka R. C. (1992). Mechanisms underlying induction of homosynaptic long-term depression in area CA1 of the hippocampus. Neuron 9, 967–975. 10.1016/0896-6273(92)90248-c [DOI] [PubMed] [Google Scholar]
- Murphy D. D., Cole N. B., Greenberger V., Segal M. (1998). Estradiol increases dendritic spine density by reducing GABA neurotransmission in hippocampal neurons. J. Neurosci. 18, 2550–2559. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ooishi Y., Kawato S., Hojo Y., Hatanaka Y., Higo S., Murakami G., et al. (2012). Modulation of synaptic plasticity in the hippocampus by hippocampus-derived estrogen androgen. J. Steroid Biochem. Mol. Biol. 131, 37–51. 10.1016/j.jsbmb.2011.10.004 [DOI] [PubMed] [Google Scholar]
- Pedram A., Razandi M., Levi E. R. (2006). Nature of functional estrogen receptors at the plasma membrane. Mol. Endocrinol. 20, 1996–2009. 10.1210/me.2005-0525 [DOI] [PubMed] [Google Scholar]
- Pettorossi V. E., Di Mauro M., Scarduzio M., Panichi R., Tozzi A., Calabresi P., et al. (2013). Modulatory role of androgenic and estrogenic neurosteroids in determining the direction of synaptic plasticity in the CA1 hippocampal region of male rats. Physiol. Rep. 1:e00185. 10.1002/phy2.185 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pettorossi V. E., Frondaroli A., Grassi S. (2011). Cyclic estrogenic fluctuation influences synaptic transmission of the medial vestibular nuclei in female rats. Acta Otolaryngol. 131, 434–439. 10.3109/00016489.2010.536992 [DOI] [PubMed] [Google Scholar]
- Pouliot W. A., Handa R. J., Beck S. G. (1996). Androgen modulates N-methyl-D-aspartate-mediated depolarization in CA1 hippocampal pyramidal cells. Synapse 23, 10–19. [DOI] [PubMed] [Google Scholar]
- Raz L., Khan M. M., Mahesh V. B., Vadlamudi R. K., Brann D. W. (2008). Rapid estrogen signalling in the brain. Neurosignals 16, 140–153. 10.1159/000111559 [DOI] [PubMed] [Google Scholar]
- Reddy D. S. (2003). Is there a physiological role for the neurosteroid THDOC in stress-sensitive conditions? Trends Pharmacol. Sci. 24, 103–106. 10.1016/s0165-6147(03)00023-3 [DOI] [PubMed] [Google Scholar]
- Reddy D. S. (2004). Anticonvulsant activity of the testosterone-derived neurosteroid 3alpha-androstanediol. Neuroreport 15, 515–518. 10.1097/00001756-200403010-00026 [DOI] [PubMed] [Google Scholar]
- Reddy D. S., Jian K. (2010). The testosterone-derived neurosteroid androstanediol is a positive allosteric modulator of GABA A receptors. J. Pharmacol. Exp. Ther. 334, 1031–1041. 10.1124/jpet.110.169854 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rudick C. N., Wooley C. S. (2001). Estrogen regulates functional inhibition of hippocampal CA1 pyramidal cells in the adult female rat. J. Neurosci. 21, 6532–6543. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Selmanoff M. K., Brodkin L. D., Weiner R. I., Siiteri P. K. (1977). Aromatization and 5alpha-reduction of androgens in discrete hypothalamic and limbic regions of the male and female rat. Endocrinology 101, 841–848. 10.1210/endo-101-3-841 [DOI] [PubMed] [Google Scholar]
- Skucas V. A., Duffy A. M., Harte-Hargrove L. C., Magagna-Poveda A., Radman T., Chakraborty G., et al. (2013). Testosterone depletion in adult male rats increases mossy fiber transmission, LTP and sprouting in area CA3 of hippocampus. J. Neurosci. 33, 2338–2355. 10.1523/JNEUROSCI.3857-12.2013 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smith C. C., McMahon L. L. (2005). Estrogen-induced increase in the magnitude of long-term potentiation occurs only when the ratio of NMDA transmission to AMPA transmission is increased. J. Neurosci. 25, 7780–7791. 10.1523/jneurosci.0762-05.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smith C. C., McMahon L. L. (2006). Estrogen-induced increase in the magnitude of long-term potentiation is prevented by blocking NR2B-containing receptors. J. Neurosci. 26, 8517–8522. 10.1523/jneurosci.5279-05.2006 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smith C. C., Vedder L. C., McMahon L. L. (2009). Estradiol and the relationship between dendritic spines, NR2B containing NMDA receptors and the magnitude of long-term potentiation at hippocampal CA3-CA1 synapses. Psychoneuroendocrinology 34(Suppl. 1), S130–S142. 10.1016/j.psyneuen.2009.06.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Staubli U. V., Ji Z. X. (1996). The induction of homo- vs. hetrosynaptic LTD in area CA1 of hippocampal slices from adult rats. Brain Res. 714, 169–176. 10.1016/0006-8993(95)01523-x [DOI] [PubMed] [Google Scholar]
- Staubli U., Lynch G. (1990). Stable depression of potentiated synaptic responses in the hippocampus with 1-5 Hz stimulation. Brain Res. 513, 113–118. 10.1016/0006-8993(90)91096-y [DOI] [PubMed] [Google Scholar]
- Tabori N. E., Stewart L. S., Znamensky V., Romeo R. D., Alves S. E., McEwen B. S., et al. (2005). Ultrastructural evidence that androgen receptors are located at extranuclear sites in the rat hippocampal formation. Neuroscience 130, 151–163. 10.1016/j.neuroscience.2004.08.048 [DOI] [PubMed] [Google Scholar]
- Tanaka M., Sokabe M. (2012). Continuous de novo synthesis of neurosteroids is required for normal synaptic transmission and plasticity in the dentate gyrus of the rat hippocampus. Neuropharmacology 62, 2373–2387. 10.1016/j.neuropharm.2012.02.007 [DOI] [PubMed] [Google Scholar]
- Vierk R., Brandt N., Rune G. M. (2014). Hippocampal estradiol synthesis and its significance for hippocampal synaptic stability in male and female animals. Neuroscience 274, 24–32. 10.1016/j.neuroscience.2014.05.003 [DOI] [PubMed] [Google Scholar]
- Vierk R., Glassmeier G., Zhou L., Brandt N., Fester L., Dudzinski D., et al. (2012). Aromatase inhibition abolishes LTP generation in female but not in male mice. J. Neurosci. 32, 8116–8126. 10.1523/JNEUROSCI.5319-11.2012 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Warren S. G., Humphreys A. G., Juraska J. M., Greenough W. T. (1995). LTP varies across the estrous cycle: enhanced synaptic plasticity in proestrus rats. Brain Res. 703, 26–30. 10.1016/0006-8993(95)01059-9 [DOI] [PubMed] [Google Scholar]
- Wong M., Moss R. L. (1992). Long-term and short-term electrophysiological effects of estrogen on the synaptic properties of hippocampal CA1 neurons. J. Neurosci. 12, 3217–3225. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Woolley C. S., Weiland N. G., McEwen B. S., Schwartzkroin P. A. (1997). Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: correlation with dendritic spine density. J. Neurosci. 17, 1848–1859. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhou Z. X., Lane M. V., Kemppainen J. A., French F. S., Wilson E. M. (1995). Specificity of ligand- dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability. Mol. Endocrinol. 9, 208–218. 10.1210/me.9.2.208 [DOI] [PubMed] [Google Scholar]